SPE 25 LIMITED

Company number NI674362 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SPE 25 LIMITED - Analysis Report

Company Number: NI674362

Analysis Date: 2025-07-29 12:17 UTC

Financial Health Assessment for SPE 25 LIMITED (NI674362)


1. Financial Health Score: D

Explanation:
The company shows persistent working capital deficits, a negative equity position, and reliance on related party funding. These are symptoms of financial distress indicating limited financial resilience. While the company is still operational and not overdue on filings, its financial “vital signs” suggest caution and the need for remedial action.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Current Assets 7,713 Low liquidity; cash dominates current assets but overall small amount to cover obligations.
Cash 7,712 Nearly all current assets are cash, which is a positive sign for short-term liquidity.
Debtors 1 Negligible trade receivables; minimal business revenue implied or very short credit terms.
Current Liabilities 10,764 Obligations due within one year exceed current assets, indicating liquidity strain.
Net Current Assets (Working Capital) -3,051 Negative working capital signals the company cannot fully meet short-term liabilities with current assets.
Shareholders’ Funds (Equity) -3,052 Negative equity (net assets) is a warning sign of accumulated losses or debt exceeding assets.
Share Capital 1 Minimal share capital, typical of a micro entity but indicates limited equity buffer.
Related Party Loans 9,964 Heavy reliance on related party funds suggests external debt or informal financing to support operations.

Interpretation of Vital Signs:

  • The company’s negative working capital (net current liabilities) is a critical symptom indicating cash flow constraints: it owes more in the short term than it holds in liquid assets.
  • The negative equity position is a serious sign of financial distress, showing the company’s liabilities exceed its assets and accumulated losses have eroded shareholder value.
  • The very low trade debtors and high reliance on cash suggest minimal ongoing trading activity or tight credit control but raise questions about business growth and revenue sustainability.
  • The existence of significant related party loans implies the company is dependent on insider funding to remain solvent, a potential risk if that support is withdrawn.

3. Diagnosis

SPE 25 LIMITED is currently in a financially fragile state. The company operates with a persistent working capital deficit and negative shareholders’ funds, indicating it has been running at a loss or carrying debts beyond its assets for multiple years. The current assets are almost entirely cash, but that cash is insufficient to cover current liabilities, which are stable but substantial relative to its size.

The company’s dependence on related party loans is symptomatic of external financing being necessary to maintain operations—this is akin to a patient needing ongoing medication or treatment to stay stable but without addressing underlying illness.

No audit is required due to the small size, but the absence of a profit and loss statement limits deeper insight into operational profitability or loss trends. The company’s recent name change could be part of a restructuring or repositioning effort.


4. Prognosis

If the current financial patterns persist—negative working capital, reliance on related party funding, and no clear path to profitability—the company faces a high risk of liquidity crises or insolvency in the medium term. Without measures to improve cash flow generation, reduce liabilities, or recapitalise, the financial health will likely deteriorate further.

However, the company is not currently in liquidation or administration, and cash balances, though low, offer some short-term survival capacity.


5. Recommendations

  • Improve Working Capital Management: Seek to reduce current liabilities or extend payment terms with creditors. Explore opportunities to increase current assets, possibly through improved cash collections or sales growth.

  • Recapitalisation: Consider injecting new equity or converting related party loans into equity to strengthen the balance sheet and reduce financial risk.

  • Revenue Growth and Diversification: As trade debtors are negligible, focus on growing trading operations and improving revenue streams to generate sustainable cash inflows.

  • Cost Control: Review and reduce overheads and non-essential expenses to preserve cash.

  • Financial Monitoring: Implement regular cash flow forecasting and stricter financial controls to detect distress early and manage liquidity proactively.

  • Professional Advice: Engage financial advisors or turnaround specialists to explore restructuring options or alternative financing.


Medical Analogy Summary

SPE 25 LIMITED exhibits symptoms of financial distress akin to a patient with chronic illness: a negative working capital "heartbeat" and negative equity "blood pressure" suggest systemic weaknesses. The company currently survives thanks to “life support” from related party funding but requires urgent “treatment” through capital injection, improved cash flow, and operational adjustments to restore financial health.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.